Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
BMC Public Health|June 21, 2006
Risk factors for pulmonary tuberculosis: a clinic-based case control study in The GambiaPhilip C Hill, Dolly Jackson-Sillah, Simon A Donkor, et al.
The Journal of Infectious Diseases|March 27, 2012
New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the futureChristian Lienhardt, Mario Raviglione, Mel Spigelman, et al.
The Lancet. Microbe|December 17, 2022
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipelineIsabel Frost, Hatim Sati, Pilar Garcia-Vello, et al.
Plos Medicine|January 28, 2010
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysisDick Menzies, Andrea Benedetti, Anita Paydar, et al.
Plos Medicine|February 28, 2020
Advances in clinical trial design: Weaving tomorrow's TB treatmentsChristian Lienhardt, Andrew Nunn, Richard Chaisson, et al.
Epidemiology (Cambridge, Mass.)|April 17, 2007
Risk factors for positive tuberculin skin test in Guinea-BissauPer Gustafson, Ida Lisse, Victor Gomes, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
The European Respiratory Journal|December 2, 2014
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultationGiovanni Battista Migliori, Christian Lienhardt, Karin Weyer, et al.
Plos Medicine|September 16, 2009
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisDick Menzies, Andrea Benedetti, Anita Paydar, et al.
JAMA|January 25, 2007
Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trialSylla Thiam, Andrea M LeFevre, Fatoumata Hane, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
BMC Public Health|June 21, 2006
Risk factors for pulmonary tuberculosis: a clinic-based case control study in The GambiaPhilip C Hill, Dolly Jackson-Sillah, Simon A Donkor, et al.
The Journal of Infectious Diseases|March 27, 2012
New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the futureChristian Lienhardt, Mario Raviglione, Mel Spigelman, et al.
The Lancet. Microbe|December 17, 2022
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipelineIsabel Frost, Hatim Sati, Pilar Garcia-Vello, et al.
Plos Medicine|January 28, 2010
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysisDick Menzies, Andrea Benedetti, Anita Paydar, et al.
Plos Medicine|February 28, 2020
Advances in clinical trial design: Weaving tomorrow's TB treatmentsChristian Lienhardt, Andrew Nunn, Richard Chaisson, et al.
Epidemiology (Cambridge, Mass.)|April 17, 2007
Risk factors for positive tuberculin skin test in Guinea-BissauPer Gustafson, Ida Lisse, Victor Gomes, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
The European Respiratory Journal|December 2, 2014
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultationGiovanni Battista Migliori, Christian Lienhardt, Karin Weyer, et al.
Plos Medicine|September 16, 2009
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisDick Menzies, Andrea Benedetti, Anita Paydar, et al.
JAMA|January 25, 2007
Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trialSylla Thiam, Andrea M LeFevre, Fatoumata Hane, et al.
Pageof 12